185 related articles for article (PubMed ID: 24086685)
1. S100A14 interacts with S100A16 and regulates its expression in human cancer cells.
Sapkota D; Costea DE; Ibrahim SO; Johannessen AC; Bruland O
PLoS One; 2013; 8(9):e76058. PubMed ID: 24086685
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
[TBL] [Abstract][Full Text] [Related]
3. S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma.
Sapkota D; Bruland O; Parajuli H; Osman TA; Teh MT; Johannessen AC; Costea DE
BMC Cancer; 2015 Sep; 15():631. PubMed ID: 26353754
[TBL] [Abstract][Full Text] [Related]
4. S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9.
Sapkota D; Bruland O; Costea DE; Haugen H; Vasstrand EN; Ibrahim SO
Eur J Cancer; 2011 Mar; 47(4):600-10. PubMed ID: 21074410
[TBL] [Abstract][Full Text] [Related]
5. Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
Zhang H; Yang Y; Xing W; Li Y; Zhang S
BMC Cancer; 2023 Nov; 23(1):1124. PubMed ID: 37978469
[TBL] [Abstract][Full Text] [Related]
6. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.
Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y
Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591
[TBL] [Abstract][Full Text] [Related]
7. S100A14, a member of the EF-hand calcium-binding proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling.
Xu C; Chen H; Wang X; Gao J; Che Y; Li Y; Ding F; Luo A; Zhang S; Liu Z
J Biol Chem; 2014 Jan; 289(2):827-37. PubMed ID: 24285542
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of 425G>a variant of calcium-binding protein S100A14 associated with poor differentiation and prognosis in gastric cancer.
Zhang Q; Zhu M; Cheng W; Xing R; Li W; Zhao M; Xu L; Li E; Luo G; Lu Y
J Cancer Res Clin Oncol; 2015 Apr; 141(4):691-703. PubMed ID: 25266115
[TBL] [Abstract][Full Text] [Related]
9. Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation.
Chen H; Yuan Y; Zhang C; Luo A; Ding F; Ma J; Yang S; Tian Y; Tong T; Zhan Q; Liu Z
J Biol Chem; 2012 May; 287(21):17109-17119. PubMed ID: 22451655
[TBL] [Abstract][Full Text] [Related]
10. S100A16 is a potential target for reshaping the tumor microenvironment in the hypoxic context of liver cancer.
Yang D; Zhao F; Zhou Y; Zhang Y; Shen J; Yu B; Zhao K; Ding Y
Int Immunopharmacol; 2024 Jun; 134():112076. PubMed ID: 38733818
[TBL] [Abstract][Full Text] [Related]
11. Identification of S100A16 as a novel adipogenesis promoting factor in 3T3-L1 cells.
Liu Y; Zhang R; Xin J; Sun Y; Li J; Wei D; Zhao AZ
Endocrinology; 2011 Mar; 152(3):903-11. PubMed ID: 21266506
[TBL] [Abstract][Full Text] [Related]
12. S100A16, a novel calcium-binding protein of the EF-hand superfamily.
Sturchler E; Cox JA; Durussel I; Weibel M; Heizmann CW
J Biol Chem; 2006 Dec; 281(50):38905-17. PubMed ID: 17030513
[TBL] [Abstract][Full Text] [Related]
13. Prognostic values and immune suppression of the S100A family in pancreatic cancer.
Zhuang H; Chen X; Dong F; Zhang Z; Zhou Z; Ma Z; Huang S; Chen B; Zhang C; Hou B
J Cell Mol Med; 2021 Mar; 25(6):3006-3018. PubMed ID: 33580614
[TBL] [Abstract][Full Text] [Related]
14. S100A14: novel modulator of terminal differentiation in esophageal cancer.
Chen H; Ma J; Sunkel B; Luo A; Ding F; Li Y; He H; Zhang S; Xu C; Jin Q; Wang Q; Liu Z
Mol Cancer Res; 2013 Dec; 11(12):1542-53. PubMed ID: 24107296
[TBL] [Abstract][Full Text] [Related]
15. S100A14 inhibits proliferation of oral carcinoma derived cells through G1-arrest.
Sapkota D; Costea DE; Blø M; Bruland O; Lorens JB; Vasstrand EN; Ibrahim SO
Oral Oncol; 2012 Mar; 48(3):219-25. PubMed ID: 22032898
[TBL] [Abstract][Full Text] [Related]
16. S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways.
Fang D; Zhang C; Xu P; Liu Y; Mo X; Sun Q; Abdelatty A; Hu C; Xu H; Zhou G; Xia H; Lan L
Cell Biol Toxicol; 2021 Aug; 37(4):555-571. PubMed ID: 33389337
[TBL] [Abstract][Full Text] [Related]
17. ADAMTS19 Suppresses Cell Migration and Invasion by Targeting S100A16 via the NF-κB Pathway in Human Gastric Cancer.
Jiang Y; Yu X; Zhao Y; Huang J; Li T; Chen H; Zhou J; Huang Z; Yang Z
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921267
[TBL] [Abstract][Full Text] [Related]
18. An Update on S100A16 in Human Cancer.
Basnet S; Vallenari EM; Maharjan U; Sharma S; Schreurs O; Sapkota D
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509106
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-6884-5p Regulates the Proliferation, Invasion, and EMT of Gastric Cancer Cells by Directly Targeting S100A16.
Lv H; Hou H; Lei H; Nie C; Chen B; Bie L; Han L; Chen X
Oncol Res; 2020 May; 28(3):225-236. PubMed ID: 31796150
[TBL] [Abstract][Full Text] [Related]
20. S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development.
Hu Y; Zhang R; Lu S; Zhang W; Wang D; Ge Y; Jiang F; Qin X; Liu Y
Int J Biol Sci; 2023; 19(7):2034-2052. PubMed ID: 37151881
[No Abstract] [Full Text] [Related]
[Next] [New Search]
